SCHEMBL7101748

SCHEMBL7101748

O=C(O)CCN1CC2=C(C1=O)C(c1ccccc1OC(F)F)C1=C(CN(CCC(=O)O)C1=O)N2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.43
PKM P14618 1/20 0.42
TSHR P16473 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALOX15 P16050 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
TP53 P04637 1/20 0.41
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA7 P43166 1/20 0.34
P2RX3 P56373 7/20 0.34
ITGB3 P05106 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7100558 0.81 PKM (0.49) NR1I2PKMTSHRKDM4ETP53
SCHEMBL7096707 0.74 ALDH1A1 (0.44) NR1I2PKMTSHRKDM4ETP53
SCHEMBL7095670 0.70 ALDH1A1 (0.50) NR1I2PKMTSHRKDM4ETP53
SCHEMBL28969743 0.68 NR1I2 (0.43) NR1I2PKMTSHRKDM4ETP53
SCHEMBL28969750 0.68 NR1I2 (0.43) NR1I2PKMTSHRKDM4ETP53
SCHEMBL7846869 0.68 NR1I2 (0.46) NR1I2PKMTSHRKDM4ETP53
SCHEMBL9806914 0.67 NR1I2 (0.76) NR1I2PKMTSHRKDM4ETP53
SCHEMBL24116896 0.64 NR1I2 (0.55) NR1I2PKMTSHRKDM4ETP53
SCHEMBL24116895 0.64 NR1I2 (0.55) NR1I2PKMTSHRKDM4ETP53
SCHEMBL30266531 0.64 NR1I2 (0.55) NR1I2PKMTSHRKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278746-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE Abbott Laboratories (US) 2003-01-29 EP claimed
WO-2001083480-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-11-08 WO claimed
EP-1131322-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-09-12 EP claimed
WO-2000024741-A2 DIHYDROPYRIDINE COMPOUNDS AND THEIR USE AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2000-05-04 WO claimed
EP-1278746-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE Abbott Laboratories (US) 2003-01-29 EP disclosed
WO-2001083480-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-11-08 WO disclosed
EP-1131322-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-09-12 EP disclosed
WO-2000024741-A2 DIHYDROPYRIDINE COMPOUNDS AND THEIR USE AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2000-05-04 WO disclosed